INR 273.95
(-0.6%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 359.43 Million | -55.81 Million | -306.73 Million | 386.57 Million | 251.39 Million | 42.01 Million |
Net Income | 398.28 Million | 228.72 Million | 238.57 Million | 325.93 Million | 246 Million | 164.31 Million |
Depreciation & Amortization | 51.31 Million | 48.34 Million | 43.93 Million | 41.09 Million | 29.74 Million | 26.88 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -102.58 Million | -336.15 Million | -602.82 Million | 12.32 Million | -3.15 Million | -165.57 Million |
Other non-cash items | 254.1 Million | -12.13 Million | 428.35 Million | 33.82 Million | 65.48 Million | 53.92 Million |
Investing Cash Flow | -35.69 Million | -23.91 Million | -82.19 Million | -107.07 Million | -202.02 Million | -85.42 Million |
Investments in PPE | -37.11 Million | -21.89 Million | -83.39 Million | -109 Million | -268.45 Million | -84.55 Million |
Acquisitions | 1.41 Million | 153 Thousand | 1.2 Million | 1.93 Million | 61.93 Million | -867 Thousand |
Investment purchases | - | -10.92 Million | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | 4.48 Million | - |
Other Investing Activities | 23.17 Million | 8.75 Million | - | - | - | - |
Financing Cash Flow | -25.44 Million | 105.11 Million | -37.42 Million | 157.57 Million | -131.06 Million | 196.21 Million |
Debt repayment | -2.06 Million | -127.12 Million | -15.41 Million | -157.57 Million | -91.26 Million | -216.17 Million |
Dividends payments | -27.51 Million | -22 Million | -22 Million | - | -39.79 Million | -19.96 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -130.82 Million | -1000.00 | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | -139.05 Million | 112.09 Million | -326.89 Million | 55.58 Million | -27.19 Million | 16.23 Million |
Other working capital | 36.47 Million | -448.24 Million | -275.92 Million | -43.26 Million | 24.03 Million | -181.8 Million |
Cash at beginning of period | 60.35 Million | 34.94 Million | 461.08 Million | 24.27 Million | 105.49 Million | 49.58 Million |
Cash at end of period | 394.3 Million | 60.35 Million | 34.94 Million | 461.08 Million | 24.27 Million | 105.49 Million |
Capital Expenditure | -37.11 Million | -21.89 Million | -83.39 Million | -109 Million | -268.45 Million | -84.55 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 333.95 Million | 25.4 Million | -426.14 Million | 436.81 Million | -81.22 Million | 55.9 Million |
Free Cash Flow | 322.32 Million | -77.71 Million | -390.13 Million | 277.56 Million | -17.05 Million | -42.54 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 86.59 Million | 129.44 Million | 398.28 Million | 98.76 Million | 90.87 Million | 79.2 Million |
Depreciation & Amortization | - | - | 51.31 Million | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -102.58 Million | - | - | - |
Other non-cash items | -86.59 Million | -129.44 Million | 254.1 Million | -98.76 Million | -90.87 Million | -79.2 Million |
Investing Cash Flow | - | - | -35.69 Million | - | - | - |
Investments in PPE | - | - | -37.11 Million | - | - | - |
Acquisitions | - | - | 1.41 Million | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | -25.44 Million | - | - | - |
Debt repayment | - | - | -2.06 Million | - | - | - |
Dividends payments | - | - | -27.51 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | -139.05 Million | - | - | - |
Other working capital | - | - | 36.47 Million | - | - | - |
Cash at beginning of period | - | - | 60.35 Million | - | - | - |
Cash at end of period | - | - | 394.3 Million | - | - | - |
Capital Expenditure | - | - | -37.11 Million | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | 333.95 Million | - | - | - |
Free Cash Flow | - | - | 322.32 Million | - | - | - |
VSTL
002892
KIRANPR
ROSSARI
HINDMILL
SUNPHARMA